Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Masaru Mimura

Showing results (641-650 of 679) with videos related to

Pageof 68
Sort By:
Psychiatry and Clinical Neurosciences|September 27, 2022
Decreased cortical gyrification and surface area in the left medial parietal cortex in patients with treatment-resistant and ultratreatment-resistant schizophreniaKazutoshi Kitajima, Shunsuke Tamura, Daiki Sasabayashi, et al.
Frontiers in Psychiatry|January 9, 2023
Development of medical device software for the screening and assessment of depression severity using data collected from a wristband-type wearable device: SWIFT study protocolTaishiro Kishimoto, Shotaro Kinoshita, Toshiaki Kikuchi, et al.
Molecular Psychiatry|October 14, 2018
Glutamatergic neurometabolite levels in major depressive disorder: a systematic review and meta-analysis of proton magnetic resonance spectroscopy studiesSho Moriguchi, Akihiro Takamiya, Yoshihiro Noda, et al.
BMC Psychiatry|November 19, 2013
Melancholic and reactive depression: a reappraisal of old categoriesJin Mizushima, Hitoshi Sakurai, Yuya Mizuno, et al.
Alzheimer'S Research & Therapy|November 21, 2024
Can the clinical sign "head-turning sign" and simple questions in "Neucop-Q" predict amyloid β pathology?Yugaku Daté, Shogyoku Bun, Keisuke Takahata, et al.
Neurology|September 29, 2022
Impact of Amyloid and Tau PET on Changes in Diagnosis and Patient ManagementSho Shimohama, Toshiki Tezuka, Keisuke Takahata, et al.
The Lancet. Psychiatry|September 12, 2015
Assertive case management versus enhanced usual care for people with mental health problems who had attempted suicide and were admitted to hospital emergency departments in Japan (ACTION-J): a multicentre, randomised controlled trialChiaki Kawanishi, Tohru Aruga, Naoki Ishizuka, et al.
Contemporary Clinical Trials Communications|September 11, 2020
The project for objective measures using computational psychiatry technology (PROMPT): Rationale, design, and methodologyTaishiro Kishimoto, Akihiro Takamiya, Kuo-Ching Liang, et al.
Environmental Health and Preventive Medicine|November 1, 2020
Study design and baseline characteristics of a population-based prospective cohort study of dementia in Japan: the Japan Prospective Studies Collaboration for Aging and Dementia (JPSC-AD)Toshiharu Ninomiya, Shigeyuki Nakaji, Tetsuya Maeda, et al.
Acta Neuropathologica Communications|May 14, 2020
Behavioral and electrophysiological evidence for a neuroprotective role of aquaporin-4 in the 5xFAD transgenic mice modelYoichiro Abe, Natsumi Ikegawa, Keitaro Yoshida, et al.
Pageof 68

Showing results (641-650 of 679) with videos related to

Sort By:
Pageof 68
Psychiatry and Clinical Neurosciences|September 27, 2022
Decreased cortical gyrification and surface area in the left medial parietal cortex in patients with treatment-resistant and ultratreatment-resistant schizophreniaKazutoshi Kitajima, Shunsuke Tamura, Daiki Sasabayashi, et al.
Frontiers in Psychiatry|January 9, 2023
Development of medical device software for the screening and assessment of depression severity using data collected from a wristband-type wearable device: SWIFT study protocolTaishiro Kishimoto, Shotaro Kinoshita, Toshiaki Kikuchi, et al.
Molecular Psychiatry|October 14, 2018
Glutamatergic neurometabolite levels in major depressive disorder: a systematic review and meta-analysis of proton magnetic resonance spectroscopy studiesSho Moriguchi, Akihiro Takamiya, Yoshihiro Noda, et al.
BMC Psychiatry|November 19, 2013
Melancholic and reactive depression: a reappraisal of old categoriesJin Mizushima, Hitoshi Sakurai, Yuya Mizuno, et al.
Alzheimer'S Research & Therapy|November 21, 2024
Can the clinical sign "head-turning sign" and simple questions in "Neucop-Q" predict amyloid β pathology?Yugaku Daté, Shogyoku Bun, Keisuke Takahata, et al.
Neurology|September 29, 2022
Impact of Amyloid and Tau PET on Changes in Diagnosis and Patient ManagementSho Shimohama, Toshiki Tezuka, Keisuke Takahata, et al.
The Lancet. Psychiatry|September 12, 2015
Assertive case management versus enhanced usual care for people with mental health problems who had attempted suicide and were admitted to hospital emergency departments in Japan (ACTION-J): a multicentre, randomised controlled trialChiaki Kawanishi, Tohru Aruga, Naoki Ishizuka, et al.
Contemporary Clinical Trials Communications|September 11, 2020
The project for objective measures using computational psychiatry technology (PROMPT): Rationale, design, and methodologyTaishiro Kishimoto, Akihiro Takamiya, Kuo-Ching Liang, et al.
Environmental Health and Preventive Medicine|November 1, 2020
Study design and baseline characteristics of a population-based prospective cohort study of dementia in Japan: the Japan Prospective Studies Collaboration for Aging and Dementia (JPSC-AD)Toshiharu Ninomiya, Shigeyuki Nakaji, Tetsuya Maeda, et al.
Acta Neuropathologica Communications|May 14, 2020
Behavioral and electrophysiological evidence for a neuroprotective role of aquaporin-4 in the 5xFAD transgenic mice modelYoichiro Abe, Natsumi Ikegawa, Keitaro Yoshida, et al.
Pageof 68